Homology Medicines Price Prediction
At this time the value of rsi of Homology Medicines' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Oversold Vs Overbought
0
Oversold | Overbought |
Homology Medicines stock price prediction is an act of determining the future value of Homology Medicines shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Homology Medicines' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Homology Medicines and does not consider all of the tangible or intangible factors available from Homology Medicines' fundamental data. We analyze noise-free headlines and recent hype associated with Homology Medicines, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Homology Medicines based on different types of headlines from major news networks to social media. The Homology stock price prediction module provides an analysis of price elasticity to changes in media outlook on Homology Medicines over a specific investment horizon. Using Homology Medicines hype-based prediction, you can estimate the value of Homology Medicines from the perspective of Homology Medicines response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Homology Medicines. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Homology Medicines to buy its stock at a price that has no basis in reality. In that case, they are not buying Homology because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Homology Medicines after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Homology |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Homology Medicines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Homology Medicines After-Hype Price Prediction Density Analysis
As far as predicting the price of Homology Medicines at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Homology Medicines or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Homology Medicines, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Homology Medicines Estimiated After-Hype Price Volatility
In the context of predicting Homology Medicines' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Homology Medicines' historical news coverage. Homology Medicines' after-hype downside and upside margins for the prediction period are 0.00 and 50.00, respectively. We have considered Homology Medicines' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Homology Medicines is out of control at this time. Analysis and calculation of next after-hype price of Homology Medicines is based on 3 months time horizon.
Homology Medicines Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Homology Medicines is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Homology Medicines backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Homology Medicines, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
25.31 | 176.60 | 1.77 | 1.92 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
Homology Medicines Hype Timeline
Homology Medicines is currently traded for 0.00. The entity has historical hype elasticity of 1.77, and average elasticity to hype of competition of -1.92. Homology is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 25.31%. %. The volatility of related hype on Homology Medicines is about 233245.28%, with the expected price after the next announcement by competition of -1.92. About 47.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Homology Medicines recorded a loss per share of 35.1. The entity had not issued any dividends in recent years. The firm had 1:18 split on the 25th of March 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.Homology Medicines Related Hype Analysis
Having access to credible news sources related to Homology Medicines' direct competition is more important than ever and may enhance your ability to predict Homology Medicines' future price movements. Getting to know how Homology Medicines' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Homology Medicines may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PASG | Passage Bio | 0.03 | 7 per month | 3.97 | 0.09 | 9.68 | (6.43) | 41.15 | |
| STOK | Stoke Therapeutics | 0.27 | 10 per month | 4.71 | 0.17 | 22.86 | (7.86) | 65.31 | |
| BCEL | Atreca Inc | 0.00 | 0 per month | 0.00 | (0.02) | 29.03 | (22.73) | 161.02 | |
| TCRR | Tcr2 Therapeutics | 0.06 | 8 per month | 3.26 | 0.06 | 5.77 | (6.25) | 43.60 | |
| ADAP | Adaptimmune Therapeutics Plc | (0.04) | 8 per month | 5.37 | 0.05 | 12.87 | (9.09) | 31.05 | |
| BDTX | Black Diamond Therapeutics | (0.32) | 8 per month | 4.37 | 0.14 | 15.26 | (7.18) | 26.97 | |
| FDMT | 4D Molecular TherapeuticsInc | (0.53) | 9 per month | 4.29 | 0.08 | 6.43 | (6.75) | 99.59 |
Homology Medicines Additional Predictive Modules
Most predictive techniques to examine Homology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Homology using various technical indicators. When you analyze Homology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Homology Medicines Predictive Indicators
The successful prediction of Homology Medicines stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Homology Medicines, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Homology Medicines based on analysis of Homology Medicines hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Homology Medicines's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Homology Medicines's related companies. Story Coverage note for Homology Medicines
The number of cover stories for Homology Medicines depends on current market conditions and Homology Medicines' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Homology Medicines is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Homology Medicines' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Homology Medicines Short Properties
Homology Medicines' future price predictability will typically decrease when Homology Medicines' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Homology Medicines often depends not only on the future outlook of the potential Homology Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Homology Medicines' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.8 M | |
| Cash And Short Term Investments | 82.7 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Homology Stock
If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |